These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2914544)

  • 21. Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
    Segami T; Suzuki Y; Ito M
    Biol Pharm Bull; 1996 Jan; 19(1):53-6. PubMed ID: 8820911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
    Collen MJ; Johnson DA; Sheridan MJ
    Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers.
    Battaglia G; Farini R; Di Mario F; Piccoli A; Plebani M; Vianello F; Burlina A; Naccarato R
    Am J Gastroenterol; 1984 Nov; 79(11):831-4. PubMed ID: 6095649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.
    Quatrini M; Basilisco G; Bianchi PA
    Gut; 1984 Oct; 25(10):1113-7. PubMed ID: 6090280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.
    Lee FI; Fielding JD; Costello FT
    Postgrad Med J; 1983 Feb; 59(688):88-92. PubMed ID: 6302650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.
    Collen MJ; Johnson DA
    Dig Dis Sci; 1992 Apr; 37(4):570-6. PubMed ID: 1551347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healing and relapse rates of duodenal ulcer with various H2 receptor antagonists.
    Ahmed W; Qureshi H; Zuberi SJ
    J Pak Med Assoc; 1988 Dec; 38(12):319-22. PubMed ID: 3148760
    [No Abstract]   [Full Text] [Related]  

  • 29. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing.
    Reynolds JC
    Ann Intern Med; 1989 Jul; 111(1):7-14. PubMed ID: 2567589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of famotidine 40 mg with ranitidine 300 mg at night in short-term duodenal ulcer healing. A South African multicentre study.
    Marks IN; Wright JP
    S Afr Med J; 1987 Jul; 72(1):18-20. PubMed ID: 2885928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
    Hartmann H; Fölsch UR
    Digestion; 1988; 39(3):156-61. PubMed ID: 3061859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamism of cytoprotective and antisecretory drugs in patients with unhealed gastric and duodenal ulcers.
    Mózsik G; Hunyady B; Garamszegi M; Németh A; Pakodi F; Vincze A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S88-92. PubMed ID: 7881027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Famotidine in the short and long-term treatment of duodenal ulcer.
    Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
    Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers. A double-blind, placebo-controlled trial.
    Van Deventer GM; Schneidman D; Walsh JH
    Am J Med; 1985 Aug; 79(2C):39-44. PubMed ID: 3898834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of misoprostol and ranitidine in the healing of duodenal ulcers. A double-blind controlled trial.
    Simjee AE; Spitaels JM; Pettengell KE; Manion GL
    S Afr Med J; 1987 Jul; 72(1):15-7. PubMed ID: 3110981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers.
    Ireland A; Colin-Jones DG; Gear P; Golding PL; Ramage JK; Williams JG; Leicester RJ; Smith CL; Ross G; Bamforth J
    Lancet; 1984 Aug; 2(8397):274-6. PubMed ID: 6146821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
    Rohner HG; Gugler R
    Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.